Assessing the public health impact of tolerance-based therapies with mathematical models
暂无分享,去创建一个
[1] Hilla Peretz,et al. The , 1966 .
[2] M. Baalen. Coevolution of recovery ability and virulence , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[3] M. Totsika,et al. Benefits and Challenges of Antivirulence Antimicrobials at the Dawn of the Post-Antibiotic Era , 2016, Current Medicinal Chemistry.
[4] S. Molin,et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. , 2004, The Journal of antimicrobial chemotherapy.
[5] P. Thrall,et al. The cost of resistance and the maintenance of genetic polymorphism in host—pathogen systems , 1994, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[6] A. Best,et al. THE COEVOLUTIONARY IMPLICATIONS OF HOST TOLERANCE , 2014, Evolution; international journal of organic evolution.
[7] J. Koella,et al. Concurrent Evolution of Resistance and Tolerance to Pathogens , 2004, The American Naturalist.
[8] M. Hadjifrangiskou,et al. The arsenal of pathogens and antivirulence therapeutic strategies for disarming them , 2016, Drug design, development and therapy.
[9] Marc Choisy,et al. Host nutrition alters the variance in parasite transmission potential , 2013, Biology Letters.
[10] D. Green,et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. , 2013, Immunity.
[11] Sylvain Gandon,et al. Imperfect vaccines and the evolution of pathogen virulence , 2001, Nature.
[12] A. Coutinho,et al. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria , 2009, Proceedings of the National Academy of Sciences.
[13] M. van Baalen. Coevolution of recovery ability and virulence. , 1998, Proceedings. Biological sciences.
[14] M. Begon,et al. Life-history trade-offs and the evolution of pathogen resistance: competition between host strains , 1994, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[15] K. P. Murphy,et al. Janeway's immunobiology , 2007 .
[16] A. White,et al. The role of ecological feedbacks in the evolution of host defence: what does theory tell us? , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[17] A. White,et al. THE EVOLUTION OF PARASITES IN RESPONSE TO TOLERANCE IN THEIR HOSTS: THE GOOD, THE BAD, AND APPARENT COMMENSALISM , 2006, Evolution; international journal of organic evolution.
[18] S. Plotkin,et al. Microbial evolution (Communication arising): Antitoxin vaccines and pathogen virulence , 2002, Nature.
[19] R. Bowers,et al. The evolution of resistance through costly acquired immunity , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[20] A. Read,et al. Animal Defenses against Infectious Agents: Is Damage Control More Important Than Pathogen Control? , 2008, PLoS biology.
[21] V. Sperandio,et al. Anti-virulence strategies to combat bacteria-mediated disease , 2010, Nature Reviews Drug Discovery.
[22] R. Bowers,et al. Three mechanisms of host resistance to microparasites-avoidance, recovery and tolerance-show different evolutionary dynamics. , 1999, Journal of theoretical biology.
[23] Herbert W. Hethcote,et al. The Mathematics of Infectious Diseases , 2000, SIAM Rev..
[24] Lars Råberg,et al. Decomposing health: tolerance and resistance to parasites in animals , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[25] David S Schneider,et al. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases , 2008, Nature Reviews Immunology.
[26] Sam P. Brown,et al. Limiting Damage during Infection: Lessons from Infection Tolerance for Novel Therapeutics , 2014, PLoS biology.
[27] I. Bechmann,et al. Sickle Hemoglobin Confers Tolerance to Plasmodium Infection , 2011, Cell.
[28] J. Kirchner,et al. EVOLUTIONARY DYNAMICS OF PATHOGEN RESISTANCE AND TOLERANCE , 2000, Evolution; international journal of organic evolution.
[29] N. Sepúlveda,et al. A Central Role for Free Heme in the Pathogenesis of Severe Sepsis , 2010, Science Translational Medicine.
[30] K. Starko,et al. Salicylates and pandemic influenza mortality, 1918-1919 pharmacology, pathology, and historic evidence. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Joshua E. Elias,et al. Role of disease-associated tolerance in infectious superspreaders , 2014, Proceedings of the National Academy of Sciences.
[32] C. Sweet,et al. Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. , 1982, The Journal of infectious diseases.
[33] R. Munford,et al. Novel therapies for septic shock over the past 4 decades. , 2011, JAMA.
[34] A. Best,et al. Maintenance of host variation in tolerance to pathogens and parasites , 2008, Proceedings of the National Academy of Sciences.
[35] Stephen P. Diggle,et al. Targeting virulence: can we make evolution-proof drugs? , 2014, Nature Reviews Microbiology.
[36] D. Earn,et al. Population-level effects of suppressing fever , 2014, Proceedings of the Royal Society B: Biological Sciences.
[37] P. Kaye. Infectious diseases of humans: Dynamics and control , 1993 .
[38] J. Koella,et al. Shared Control of Epidemiological Traits in a Coevolutionary Model of Host‐Parasite Interactions , 2003, The American Naturalist.
[39] Charles Flexner,et al. HIV drug development: the next 25 years , 2007, Nature Reviews Drug Discovery.
[40] Ruslan Medzhitov,et al. Disease Tolerance as a Defense Strategy , 2012, Science.
[41] W. O. Kermack,et al. A contribution to the mathematical theory of epidemics , 1927 .